VUGENE secures 1 million euros to revolutionise biological research

Powering Lithuania’s biotech future: VUGENE has raised €1 million to expand its multi-omics data analysis platform globally.

By helping scientists better understand complex biological data in health and disease research, this Lithuanian startup is already working with leading research centres and biotech companies. The funding round – led by Superhero Capital and joined by NGL Ventures, Coinvest Capital, and angel investors – highlights growing international confidence in Lithuania’s deep-tech potential.

Our WALLESS team, led by Partner Andrius Ivanauskas and Senior Associate Ieva Pikaitė, together with Partner Dr Mindaugas Lukas, had VUGENE’s back on legal and tax details.  Nothing makes us happier than clearing the runway for breakthroughs that can push life‑science research forward.